Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Gallagher

Showing results (71-80 of 108) with videos related to

Pageof 11
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 7, 2006
Teriparatide increases bone formation in modeling and remodeling osteons and enhances IGF-II immunoreactivity in postmenopausal women with osteoporosisYanfei L Ma, Qingqiang Zeng, David W Donley, et al.
The Journal of Clinical Endocrinology and Metabolism|April 21, 2005
Early changes in biochemical markers of bone formation correlate with improvements in bone structure during teriparatide therapyHarald Dobnig, Adrien Sipos, Yebin Jiang, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 18, 2017
Improved Screening Test for Idiopathic Infantile Hypercalcemia Confirms Residual Levels of Serum 24,25-(OH)<sub>2</sub> D<sub>3</sub> in Affected PatientsMartin Kaufmann, Nicole Morse, Billy Joe Molloy, et al.
JACC. Cardiooncology|August 16, 2021
Left Ventricular Assist Devices in Patients With Active MalignanciesIlana Schlam, Andy Y Lee, Song Li, et al.
Contemporary Clinical Trials Communications|July 17, 2018
PALINA: A phase II safety study of palbociclib in combination with letrozole or fulvestrant in African American women with hormone receptor positive HER2 negative advanced breast cancerFilipa Lynce, Mervat Saleh, Ayesha Shajahan-Haq, et al.
The Journal of Clinical Endocrinology and Metabolism|February 4, 2011
Effects of denosumab treatment and discontinuation on bone mineral density and bone turnover markers in postmenopausal women with low bone massHenry G Bone, Michael A Bolognese, Chui Kin Yuen, et al.
Contemporary Clinical Trials Communications|January 15, 2025
Comorbidities And Reducing InEquitieS (CARES): Feasibility of self-monitoring and community health worker support in management of comorbidities among Black breast and prostate cancer patientsLaura C Schubel, Ana Barac, Michelle Magee, et al.
JMIR Formative Research|October 8, 2025
Feasibility and Acceptability of a Positive Psychological Intervention for Patients With Metastatic Breast Cancer: Pre-Post Pilot StudyClaire C Conley, Elizabeth L Addington, Mikaela Velazquez-Sosa, et al.
Nucleic Acids Research|June 28, 2023
Direct m6A recognition by IMP1 underlays an alternative model of target selection for non-canonical methyl-readersGiuseppe Nicastro, Giancarlo Abis, Pierre Klein, et al.
Clinical Nutrition (Edinburgh, Scotland)|October 2, 2024
The effect of active vitamin D supplementation on body weight and composition: A meta-analysis of individual participant dataSabrina M Oussaada, Isis Akkermans, Sandeep Chohan, et al.
Pageof 11

Showing results (71-80 of 108) with videos related to

Sort By:
Pageof 11
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 7, 2006
Teriparatide increases bone formation in modeling and remodeling osteons and enhances IGF-II immunoreactivity in postmenopausal women with osteoporosisYanfei L Ma, Qingqiang Zeng, David W Donley, et al.
The Journal of Clinical Endocrinology and Metabolism|April 21, 2005
Early changes in biochemical markers of bone formation correlate with improvements in bone structure during teriparatide therapyHarald Dobnig, Adrien Sipos, Yebin Jiang, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 18, 2017
Improved Screening Test for Idiopathic Infantile Hypercalcemia Confirms Residual Levels of Serum 24,25-(OH)<sub>2</sub> D<sub>3</sub> in Affected PatientsMartin Kaufmann, Nicole Morse, Billy Joe Molloy, et al.
JACC. Cardiooncology|August 16, 2021
Left Ventricular Assist Devices in Patients With Active MalignanciesIlana Schlam, Andy Y Lee, Song Li, et al.
Contemporary Clinical Trials Communications|July 17, 2018
PALINA: A phase II safety study of palbociclib in combination with letrozole or fulvestrant in African American women with hormone receptor positive HER2 negative advanced breast cancerFilipa Lynce, Mervat Saleh, Ayesha Shajahan-Haq, et al.
The Journal of Clinical Endocrinology and Metabolism|February 4, 2011
Effects of denosumab treatment and discontinuation on bone mineral density and bone turnover markers in postmenopausal women with low bone massHenry G Bone, Michael A Bolognese, Chui Kin Yuen, et al.
Contemporary Clinical Trials Communications|January 15, 2025
Comorbidities And Reducing InEquitieS (CARES): Feasibility of self-monitoring and community health worker support in management of comorbidities among Black breast and prostate cancer patientsLaura C Schubel, Ana Barac, Michelle Magee, et al.
JMIR Formative Research|October 8, 2025
Feasibility and Acceptability of a Positive Psychological Intervention for Patients With Metastatic Breast Cancer: Pre-Post Pilot StudyClaire C Conley, Elizabeth L Addington, Mikaela Velazquez-Sosa, et al.
Nucleic Acids Research|June 28, 2023
Direct m6A recognition by IMP1 underlays an alternative model of target selection for non-canonical methyl-readersGiuseppe Nicastro, Giancarlo Abis, Pierre Klein, et al.
Clinical Nutrition (Edinburgh, Scotland)|October 2, 2024
The effect of active vitamin D supplementation on body weight and composition: A meta-analysis of individual participant dataSabrina M Oussaada, Isis Akkermans, Sandeep Chohan, et al.
Pageof 11